Retatrutide vs Semaglutide and Tirzepatide: What the New Phase 3 Data Really Show
New TRIUMPH-2 Phase 3 data add important evidence for retatrutide. Here is what the results show, why cross-trial comparisons are limited, and what direct comparison studies may answer next.